IP Library Granted Patent US 8,158,801
Granted Patent B2
US 8,158,801 · App. 11/535,458 · Granted Apr 17, 2012

Violet laser excitable dyes and their method of use

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,158,801
App. No.
11/535,458
Granted
Apr 17, 2012
Kind
B2
Abstract

The present invention provides dye compounds optimally excited at about 400 nm and have a Stokes shift of at least about 80 nm. These dyes find use in detection of analyte in a sample and the preparation of dye-conjugates.

Claims (36)

1. A compound that is:

wherein Su is succinimidyl.

2. A method for detecting an analyte in a sample, wherein the method comprises:

a. combining a compound according to claim 1 with a sample to form a combined sample;

b. incubating the combined sample for a sufficient amount of time for the compound to associate with the analyte in the sample to form an incubated sample;

c. illuminating the incubated sample with an appropriate wavelength to form an illuminated sample; and

d. detecting the illuminated sample whereby the analyte in the sample is detected.

3. The method according to claim 2 , wherein the illumination and/or detecting step comprises a flow cytometer.

4. A method for forming a dye conjugate, wherein the method comprises:

a. combining a compound according to claim 1 with a carrier molecule to form a combined sample; and

b. incubating the combined sample for a sufficient amount of time for the compound to form a covalent bond with the carrier molecule,

wherein the carrier molecule comprises an amino acid, a peptide, a protein, a polysaccharide, a nucleotide, a nucleoside, an oligonucleotide, a nucleic acid, a hapten, a psoralen, a drug, a hormone, a lipid, a lipid assembly, a synthetic polymer, a polymeric microparticle, a biological cell or a virus.

5. The method according to claim 4 , further comprising separating un-conjugated compound from the compounds that formed a covalent bond with the carrier molecule.

6. A method for evaluating the viability of cells in a sample, comprising:

a. combining a compound according to claim 1 with a sample to form a combined sample;

b. incubating the combined sample for a sufficient amount of time for the compound to form a covalent bond with amine groups on a cell membrane of live cells and to form covalent bonds with amine groups inside dead cells in the sample to form an incubated sample;

c. illuminating the incubated sample with an appropriate wavelength to form an illuminated sample; and

d. detecting the illuminated sample whereby the viability of cells in a sample is evaluated.

7. A kit for detecting an analyte in a sample, wherein the kit comprises:

a. a compound according to claim 1 ; and

b. instructions for detecting the analyte.

8. A method for forming a dye conjugate, wherein the method comprises:

a. combining a compound according to claim 1 with a carrier molecule to form a combined sample; and

b. incubating the combined sample for a sufficient amount of time for the compound to form a covalent bond with the carrier molecule,

wherein the carrier molecule comprises an antibody or fragment thereof, an avidin or streptavidin, a biotin, a blood component protein, a dextran, an enzyme, an enzyme inhibitor, a hormone, an IgG binding protein, a fluorescent protein, a growth factor, a lectin, a lipopolysaccharide, a microorganism, a metal binding protein, a metal chelating moiety, a non-biological microparticle, a peptide toxin, a phosphotidylserinebinding protein, a structural protein, a small-molecule drug, or a tyramide.

9. The method according to claim 8 , further comprising separating un-conjugated compound from the compounds that formed a covalent bond with the carrier molecule.

10. A method for forming a dye conjugate, wherein the method comprises:

a. combining a compound according to claim 1 with a solid support to form a combined sample; and

b. incubating the combined sample for a sufficient amount of time for the compound to form a covalent bond with the solid support,

wherein the solid support comprises Sepharose, poly(acrylate), polystyrene, poly(acrylamide), polyol, agarose, agar, cellulose, dextran, starch, FICOLL, heparin, glycogen, amylopectin, mannan, inulin, nitrocellulose, diazocellulose or starch.

11. The method according to claim 10 , further comprising separating un-conjugated compound from the compounds that formed a covalent bond with the solid support.

12. A method for forming a dye conjugate, wherein the method comprises:

a. combining a compound according to claim 1 with a solid support to form a combined sample; and

b. incubating the combined sample for a sufficient amount of time for the compound to form a covalent bond with the solid support,

wherein the solid support comprises a microfluidic chip, a silicon chip, a microscope slide, a microplate well, silica gels, polymeric membranes, particles, derivatized plastic films, glass beads, cotton, plastic beads, alumina gels, polysaccharides, polyvinylchloride, polypropylene, polyethylene, nylon, latex bead, magnetic bead, paramagnetic bead, or superparamagnetic bead.

13. The method according to claim 12 , further comprising separating un-conjugated compound from the compounds that formed a covalent bond with the solid support.

Assignments (2)
LIEN RELEASE Recorded Apr 9, 2013
From: BANK OF AMERICA, N.A.
To: LIFE TECHNOLOGIES CORPORATION
Reel/Frame 030182/0461 →
SECURITY AGREEMENT Recorded Dec 5, 2008
From: LIFE TECHNOLOGIES CORPORATION
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 021975/0467 →